BioXcel Therapeutics (BTAI) To Launch Smartwatch Agitation Detection Study - BMO Capital
Tweet Send to a Friend
BMO Capital analyst Do Kim reiterated an Outperform rating and $21.00 price target on BioXcel Therapeutics (NASDAQ: BTAI) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
